IM Cannabis (IMCC) Accumulated Expenses (2019 - 2024)

IM Cannabis' Accumulated Expenses history runs 6 years deep, the most recent figure standing at $5.6 million for Q3 2024.

• On a quarterly basis, Accumulated Expenses rose 311.35% year-over-year to $5.6 million in Q3 2024; TTM through Sep 2024 was $5.6 million, a 311.35% increase from a year earlier, with the FY2023 full-year figure at $1.6 million, down 16.98% from the prior year.
• Accumulated Expenses climbed to $5.6 million in Q3 2024 per IMCC's latest filing, from $1.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $8.8 million in Q3 2021 and bottomed at $1.4 million in Q3 2023.
• The 5-year median for Accumulated Expenses is $2.0 million (2022), against an average of $2.9 million.
• Across the five-year window, Accumulated Expenses tumbled 77.4% in 2022 and jumped 311.35% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $2.7 million in 2020, then jumped by 78.61% to $4.8 million in 2021, then tumbled by 62.57% to $1.8 million in 2022, then fell by 14.1% to $1.5 million in 2023, then jumped by 264.55% to $5.6 million in 2024.
• Per Business Quant, the three latest IMCC Accumulated Expenses figures stand at $5.6 million (Q3 2024), $1.6 million (Q1 2024), and $1.5 million (Q4 2023).